Authors
Latest:
Next-gen AI: Widespread adoption hinges on trustEmbracing AI 2.0 and modern machine learning as foundational tools to deepening HCP engagement
Latest:
A Process-Based Approach To Aggregate SpendA Process-Based Assessment (PBA) is the first step to analyzing reporting needs
Latest:
Reshaping Biotechnology's Financing Relay RaceThe current economic downturn may fuel the creation of new, more sustainable business models
Latest:
Three Areas to Drive Supply Chain ValueStrategic and proactive thinking are vital in providing supply chain leaders with an opportunity to shift their focus to a more holistic, value-centered approach.
Latest:
Optimizing the Patient Journey Through High-Touch, High-Tech Services for Innovative and Novel TherapiesDana Edwards shares strategies and best practices for developing and implementing high-tech, high-touch patient support programs for innovative and novel therapies to help connect patients to the services they need.
Latest:
Manufacturing at the Speed of AIHow pharma can harness digitalization all the way through commercialization
Latest:
Fostering Patient Engagement with PortalsSix engagement tips for companies to consider to improve patient use of portals
Latest:
How pharma and HCPs can support backlogged pandemic patientsFocusing on key groups will drive the greatest impact in health outcomes
Latest:
Adding Might to ‘Specialty Lite’Not quite specialty, not quite retail: Cost-effective access and support strategies for a growing, yet underserved, treatment market
Latest:
Why Reliable Pharma Shipping Outweighs CostAlthough companies are faced with constraints, regulations, and challenges in this space, the positives supersede the negatives.
Latest:
From Toggling Tediously Between Systems to Achieving Whole-Person CareThe rationale behind transforming case management in healthcare.
Latest:
Navigating Digital Transformation Fatigue: The Strategy for Success in Regulated IndustriesDigital transformation initiatives are often complex endeavors that can significantly impact the way organizations operate.
Latest:
The True Reliability of Real-World DataOutlining five questions that should be considered when assessing if RWD is “fit for purpose” in pharma research—and ultimately clinical and pharmacy decision support
Latest:
Harnessing the Potential of Data to Deliver the Future of HealthcareFaster approvals, more accurate and timely medicines monitoring—all enabled by harmonized, consistent and reliable data—will drive improved patient outcomes.
Latest:
Developing Your Roadmap to Pharma 4.0Questions to ask before transitioning into new technologies. By Yvonne Duckworth and Cory Perelman.
Latest:
Patient Centricity in the Pharma Supply ChainThe importance of industry, as it moves forward, in focusing on patient-centered care and prioritizing patient needs across the supply chain.
Latest:
The Evolving Value Assessment Landscape in the USHow current frameworks influence coverage decisions and pricing negotiations.
Latest:
What Makes Hub Programs Successful?Outlining the core functional skill sets of the most effective hub programs—all toward the goal of helping patients get on prescriptions as quickly as possible
Latest:
Telehealth: Connecting the DotsHow pharma can speed up the journey with direct-to-patient models
Latest:
Maximizing HCP engagement as the definition of a sales ‘call’ expandsHow pharma’s retooling of its promotional efforts in the post-pandemic era impacts sizing and targeting, two crucial foundational pieces to successful commercialization
Latest:
After a Decade of Regulatory Transformation, What’s Next?Following a decade of solid groundwork to modernize regulatory information management in life sciences, leading companies have now shifted their focus to how they might exploit this new digital landscape
Latest:
Global Study Warns Cancer Cases to Triple in Low-HDI Countries by 2050, Urging Enhanced Prevention, Care InitiativesBy 2050, study estimates that cancer incidence and mortality rates will nearly triple in low-Human Development Index countries, highlighting an urgent need for enhanced global cancer prevention, early detection, and treatment strategies to address growing disparities.
Latest:
Succeeding with Fit-for-Purpose AIHow artificial intelligence is improving the patient experience
Latest:
Drug Shortages: A Chronic Problem, but New Opportunities Present ThemselvesWhile this concern is causing ripples in the global supply chain, technological and regulatory advances can help address the issue
Latest:
Developing a Successful Data & Analytics Strategy: Four Common QuestionsA comprehensive data and analytics strategy is now table stakes for pharmaceutical and life science organizations, writes Simon Andrews
Latest:
The Impact of 340B on Commercial ContractsDuplicate rebates have resulted in revenue leakage for manufacturers.
